To study the cancer development in ER/PR/HER2-negative cells carrying a BRCA1 germline mutation, we established a protocol for the generation of human BRCA1 organoids from ER/PR/HER2-negative heterozygous BRCA1 cells. The gene discussed is BRCA1; the disease is cancer.